PLT 1.39% 73.0¢ plenti group limited

things are moving along, page-7

  1. 85 Posts.
    anoir

    re your question re Digene applicability for women < 30...this is a regulatory approval issue with the FDA and most likely will not ever be sanctioned for women < 30 as they are not really at risk of developing cervical cancer and have a tendency for their immune systems to shed the HPV virus naturally.

    Cervical cancer screening whether it be via traditional Pap, LBC, Truscreen or HPV testing is only applicable for women > 30
 
watchlist Created with Sketch. Add PLT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.